Immune ThrombocytoPenia * Before and After Therapy study

Withdrawn

• Conditions: Idiopathic Thrombocytopenic Purpura; ITP; 10035534; 10003816

• Registration Number: NL-OMON38836
• Lead Sponsor: Sanquin Bloedbank

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

newly diagnosed, untreated ITP

Exclusion Criteria

anders

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Platelet activity, according to the PATS (P10.127) test and platelet<br /><br>auto-antibodies according to the MAIPA (P12.106).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>na</p><br>